FindTrial
Sign In

Correlation analysis between exhaled nitric oxide and bronchial tuberculosis

Application value of exhaled nitric oxide in bronchial tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018375
Enrollment
Unknown
Registered
2018-09-14
Start date
2018-09-15
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial tuberculosis

Interventions

TBTB:FeNO detection
control group:FeNO detection

Sponsors

Jiangxi Provincial Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Bronchial tuberculosis was confirmed by bronchoscopy.

Exclusion criteria

Exclusion criteria: 1. Combined with asthma, eosinophilic inflammation and other diseases affecting FeNO; 2. History of nasal surgery; 3. A History of upper and lower respiratory tract infections within 1 month; 4. A history of systemic or topical medication within 2 weeks; 5. Women during menstruation or pregnancy; 6. Use of hormones during treatment.

Design outcomes

Primary

MeasureTime frame
Fractional exhaled nitric oxide;T-SPOT.TB;erythrocyte sedimentation rate (ESR);PPD test results;Mycobacterium tuberculosis;—

Contacts

Public ContactLi Jie

Jiangxi Provincial Chest Hospital

lijie_3608@126.com+86 15270831364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026